There is no pressuring the FDA unless you are BP like PFE etc. Not so much pressure as influence. Big Pharma pays the bulk of the FDA's budget in fees and also hires a lot of former FDA officials once their government careers end. Little biotech's have to rely on building a better mousetrap.

Generex needs to get their data from the current research put together in a IND app for the FDA. Once we get official trials going, especially as the trial moves into a later phase there will be some attention for sure.